TY - JOUR T1 - 欧洲呼吸杂志JO - - EUR呼吸杂志DO - 10.1183 / 13993003.00582-2017 VL - 医院获得性肺炎和呼吸机相关肺炎JF管理国际ERS / ESICM / ESCMID /阿拉特准则50 - 3SP - 1700582 AU - 托雷斯，安东尼AU - 尼德曼，迈克尔S. AU - 沙斯特尔，让非盟 - Ewig，圣地亚哥AU - 费尔南德斯 - 班德略斯，帕特里夏AU - Hanberger，哈坎AU - Kollef，马林AU - 李巴斯，布冯AU -卢纳，卡洛斯M. AU - 马丁洛埃切斯，伊格纳西奥AU - 派瓦，J.阿图尔AU - 读取，罗伯特C. AU - Rigau，大卫AU - 坦西，让弗朗索瓦AU - 威尔特，托比亚斯AU - Wunderink，理查德Y1 - 2017年/ 9月1日UR - //www.qdcxjkg.com/content/50/3/1700582.abstract N2 - 最新欧洲指南和医院获得性肺炎（HAP）和呼吸机相关肺炎专案组报告（VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empiric treatment, response to treatment, new antibiotics or new forms of antibiotic administration and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent.The European Respiratory Society launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases, were invited to participate and appointed their representatives. The Latin American Thoracic Association was also invited.A total of 15 experts and two methodologists made up the panel. Three experts from the USA were also invited (Michael S. Niederman, Marin Kollef and Richard Wunderink).Applying the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology, the panel selected seven PICO (population–intervention–comparison–outcome) questions that generated a series of recommendations for HAP/VAP diagnosis, treatment and prevention.ERS/ESICM/ESCMID/ALAT evidence-based recommendations for HAP/VAP diagnosis, treatment and prevention http://ow.ly/dGhv30dAVoa ER -